18 results on '"Kater, Arnon P."'
Search Results
2. Electron transport chain and mTOR inhibition synergistically decrease CD40 signaling and counteract venetoclax resistance in chronic lymphocytic leukemia
3. Inhibition of casein kinase 2 sensitizes mantle cell lymphoma to venetoclax through MCL-1 downregulation
4. T-cell dysfunction in chronic lymphocytic leukemia from an epigenetic perspective
5. Response in patients with BIRC3-mutated relapsed/refractory chronic lymphocytic leukemia treated with fixed-duration venetoclax and rituximab
6. Feasibility and efficacy of addition of individualized-dose lenalidomide to chlorambucil and rituximab as first-line treatment in elderly and FCR-unfit patients with advanced chronic lymphocytic leukemia
7. CD40 signaling instructs chronic lymphocytic leukemia cells to attract monocytes via the CCR2 axis
8. Chronic lymphocytic leukemia cells are active participants in microenvironmental cross-talk
9. Incidence and management of toxicity associated with ibrutinib and idelalisib: a practical approach
10. Innate lymphoid cells are expanded and functionally altered in chronic lymphocytic leukemia
11. Electron transport chain and mTOR inhibition synergistically decrease CD40 signaling and counteract venetoclax resistance in chronic lymphocytic leukemia.
12. Final results and overall survival data from a phase II study of acalabrutinib monotherapy in patients with relapsed/refractory mantle cell lymphoma, including those with poor prognostic factors.
13. Inhibition of casein kinase 2 sensitizes mantle cell lymphoma to venetoclax through MCL-1 downregulation.
14. Genomic arrays identify high-risk chronic lymphocytic leukemia with genomic complexity: a multi-center study.
15. Feasibility and efficacy of addition of individualized-dose lenalidomide to chlorambucil and rituximab as first-line treatment in elderly and FCR-unfit patients with advanced chronic lymphocytic leukemia.
16. 'Trained immunity': consequences for lymphoid malignancies.
17. Chronic lymphocytic leukemia development is accelerated in mice with deficiency of the pro-apoptotic regulator NOXA.
18. Resistance to ABT-199 induced by microenvironmental signals in chronic lymphocytic leukemia can be counteracted by CD20 antibodies or kinase inhibitors.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.